Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PVR contributors: mct/npt/pgu - updated : 27-03-2014
HGNC name poliovirus receptor
HGNC id 9705
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveintestinelarge intestinecolon  
 liver   highly
 stomach    
Respiratorylung   highly
cells
SystemCellPubmedSpeciesStageRna symbol
not specificstromal cell
Skeletonosteoclast
cell lineage
cell lines
fluid/secretion
at STAGE
physiological period embryo
Text structure giving rise to spinal cord anterior motor neurons
PROTEIN
PHYSICAL PROPERTIES globular
STRUCTURE
motifs/domains
  • 3 Ig-like extracellular domains, D1-D3, where D1 is recognized by the virus
  • HOMOLOGY
    Homologene
    FAMILY
  • immunoglobulin superfamily
  • nectin family
  • CATEGORY receptor
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
        intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    basic FUNCTION
  • playing an important role in cellular function, in cell adhesion and migration
  • binding of PVR with CD226 negatively regulates osteoclast formation
  • implicated in the formation of adherence junctions and enhancing cell proliferation via the stimulation of serum and platelet-derived growth factor through the Ras-Raf-MEK-ERK signaling pathway
  • at least in part, enhances the proliferation of ras-mutated cells
  • expressed on normal cells of an epithelial origin, such as endothelial cells
  • has a key role in regulating NK cell function
  • appeared to be a key ligand recognized by CD226 in NK cell-mediated suppression of metastases, and CD226-mediated suppression coincided with perforin activity
  • enhances cell migration, proliferation, and metastasis
  • cell surface protein that exert immune regulatory functions
  • IFNG-inducible immune regulatory protein on the surface of endothelial cells that attenuates the acquisition of effector functions in CD8 T cells
  • structure of TIGIT immunoreceptor bound to PVR reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding of PVR with CD226 negatively regulates osteoclast formation and cellular fusion process may be inhibited by the PVR-mediated signaling
  • interacting with CD96 (interaction may be crucial in developmental processes)
  • TIGIT, a new protein expressed by T and NK cells binds to PVR and PVR-like receptors and inhibits T cell activity indirectly through the manipulation of dendritic cells activity
  • TIGIT binds to PVR on the dendritic cell surface, driving them to a more tolerogenic phenotype
  • TIGIT is a novel inhibitory receptor, interacting with two ligands: PVR and NECTIN2 and to inhibit human NK-cell cytotoxicity
  • TIGIT/PVR engagement suppresses interferon-gamma (IFNG1) production of NK cells
  • TIGIT was selectively up-regulated on NK cells, along with high expression of its ligand, poliovirus receptor (PVR/CD155), on hepatocytes during liver regeneration
  • PVR engages the activating receptor CD226, the inhibitory receptor TIGIT, and the CD96 receptor with both activating and inhibitory functions
  • TIGIT, upon interaction with either of its two ligands, NECTIN2 or poliovirus receptor (PVR), inhibits activation of T and NK cells
  • cell & other
    REGULATION
    Other regulated by NRF1 (nuclear respiratory factor 1)
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in cancer cells has clinical significance for prognostic evaluation of patients with primary pulmonary adenocarcinoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS